British Journal of Surgery 1998, 85, 255–260
Prognostic factors in a series of 297 patients with gastric
adenocarcinoma undergoing surgical resection
F. S
´
ANCHEZ-BUENO, J. A. GARCIA-MARCILLA, D. PEREZ-FLORES*,
J. M. P
´
EREZ-ABAD, R. VICENTE, F. ARANDA, P. RAMIREZ and P. PARRILLA
Department of General Surgery, ‘Virgen de la Arrixaca’ University Hospital and *Department of Medical Statistics, University of Murcia,
Murcia, Spain
Correspondence to: Professor F. S´anchez-Bueno, Servicio de Cirug´ıa, 3
a
Planta, Hospital Universitario ‘Virgen de la Arrixaca’, 30 120, Murcia,
Spain
Background Gastric cancer has a poor prognosis. The aim of this study was to determine the
influence of several clinicopathological variables on outcome in a series of 297 Western patients
undergoing surgical resection for gastric adenocarcinoma.
Methods The results were analysed retrospectively and prognostic factors were identified in a
univariate and Cox proportional hazards regression model. Mean patient age at the time of
operation was 61·9 years; 65·7 per cent were men. Mean follow-up was 7·8 (range 1–15) years. Of
the 297 patients undergoing surgery, 70 per cent had subtotal gastrectomy, 26·3 per cent underwent
total gastrectomy and 3·7 per cent had proximal gastrectomy.
Results The overall survival rate was 38·9 per cent at 5 years. In the univariate analysis, survival-
related factors were weight loss (P 0·05), abdominal mass (P 0·01), dysphagia (P 0·001), type
of gastrectomy (subtotal gastrectomy versus total gastrectomy, P 0·001), intention of resection
(curative versus palliative resection, P 0·001), tumour site (P 0·001), histopathological grade (low
versus high grade, P 0·05), tumour diameter less than 3 cm (P 0·001), degree of gastric wall
invasion (P 0·001), degree of lymph node invasion (P 0·001) and stage of the neoplasia
(P 0·001). Other variables had no significant influence. In the multivariate analysis, degree of
gastric wall invasion, lymph node invasion, tumour size and dysphagia at presentation were the only
independent prognostic variables.
Conclusion From these data it was possible to derive a prognostic index with which patients could be
classified as at low, intermediate or high risk.
Gastric cancer is one of the major causes of cancer-
related death in the world, even though its incidence has
decreased over the past decade
1
. The prognosis is
generally poor, especially in Western countries
2,3
where
the overall survival rate at 5 years has not changed, oscil-
lating between 8 and 26 per cent, even though the resect-
ability rate has increased (currently 60–80 per cent) and
the postoperative mortality rate has dropped from 14 to 6
per cent
4–8
. The poor survival is related to delayed diag-
nosis and frequent local and regional recurrence. Several
variables representing pathological, clinical and thera-
peutic characteristics have already been studied in
numerous retrospective reports
9–15
in an attempt to
identify prognostic indicators in patients with gastric
cancer and, recently
16
, to help define high-risk patients
who may benefit from adjuvant therapy.
The aim of this paper was to determine the influence of
several clinicopathological variables on outcome in a
series of 297 patients undergoing surgical resection for
gastric adenocarcinoma. The results were analysed retro-
spectively and prognostic factors were identified in a
univariate and Cox proportional hazards regression
model.
Patients and methods
Between January 1979 and December 1994, 321 patients with
gastric adenocarcinoma (excluding patients with cancer of the
gastric cardia) underwent surgical resection. Excluding 24
operative deaths (defined as those occurring within 30 days of
operation), the remaining 297 patients were discharged from
hospital and are the subject of study. Mean follow-up was 7·8
(range 1–15) years. Mean patient age at the time of operation
was 61·9 (range 30–88) years; 195 patients were men (65·7 per
cent) and 102 women (34·3 per cent). Of the 297 patients under-
going surgery, 208 (70·0 per cent) had subtotal gastrectomy, 78
(26·3 per cent) underwent total gastrectomy and the remaining
11 (3·7 per cent) had proximal gastrectomy.
Three types of variable were analysed in the survival analysis:
(1) clinical variables including sex, age, evolution time (time
elapsed from the appearance of the first symptoms to the time of
treatment) and the presence or absence of more meaningful
clinical data (epigastric pain, pyloric obstruction, gastrointestinal
haemorrhage, weight loss, dysphagia and a palpable abdominal
mass); (2) treatment-related variables including the type of
operation performed and the intention of the resection –
curative (all gross disease is removed at operation) or palliative
(gross disease remaining at the conclusion of the operation); and
(3) anatomicopathological variables including tumour location,
size, tumour structure (exophytic versus non-exophytic), degree
of tumour differentiation, extent of the disease (tumour confined
to the gastric wall versus invading adjacent organs or distant
metastasis) and tumour node metastasis (TNM) stage (Union
Internacional Contra la Cancrum classification
17
).
Deaths from causes other than gastric cancer were treated as
censored data at the time of death. The survival data are
expressed as 5-year survival rates with 95 per cent confidence
intervals (c.i.). Survival rates in the different groups were
calculated with the Kaplan–Meier estimation method, and
survival curves were compared with the log rank test or with its
version for testing trends if the categories of the grouping
variable were ordered
18
.
The possible prognostic factors were evaluated with the Cox
proportional hazards regression model
19
by means of a backward Paper accepted 9 June 1997
© 1998 Blackwell Science Ltd 255
Downloaded from https://academic.oup.com/bjs/article/85/2/255/6269845 by guest on 02 January 2024